ContraFect Corporation - Company & Market Research Reports

ContraFect Corporation is a biotechnology company that develops therapeutic protein and antibody products for life-threatening, drug-resistant infectious diseases in the United States. Its lead product candidates consist of CF-301, a lysin that completed Phase 1 human clinical trials for the treatment of Staph aureus bacteremia; and CF-404, a combination of human monoclonal antibodies for the treatment of life-threatening seasonal and pandemic varieties of influenza. ContraFect Corporation was founded in 2008 and is headquartered in Yonkers, New York.

Influenza A Viral Infections Drug Development Pipeline Review, 2018 - Product Thumbnail Image

Influenza A Viral Infections Drug Development Pipeline Review, 2018

  • Report
  • 188 Pages
From
Swine and Avian Influenza Drug Development Pipeline Review, 2017 - Product Thumbnail Image

Swine and Avian Influenza Drug Development Pipeline Review, 2017

  • Report
  • 119 Pages
From
Methicillin-Resistant Staphylococcus aureus (MRSA) Infections - Pipeline Review, H1 2018 - Product Thumbnail Image

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections - Pipeline Review, H1 2018

  • Report
  • 390 Pages
From
Methicillin-Susceptible Staphylococcus aureus (MSSA) Infections - Pipeline Review, H1 2018 - Product Thumbnail Image

Methicillin-Susceptible Staphylococcus aureus (MSSA) Infections - Pipeline Review, H1 2018

  • Report
  • 48 Pages
From
Meningitis - Pipeline Review, H2 2017 - Product Thumbnail Image

Meningitis - Pipeline Review, H2 2017

  • Report
  • 53 Pages
From
Streptococcal Pneumonia - Pipeline Review, H2 2016 - Product Thumbnail Image

Streptococcal Pneumonia - Pipeline Review, H2 2016

  • Report
  • 160 Pages
From
Bacterial Pneumonia - Pipeline Review, H2 2016 - Product Thumbnail Image

Bacterial Pneumonia - Pipeline Review, H2 2016

  • Report
  • 212 Pages
From
Meningitis - Pipeline Review, H1 2017 - Product Thumbnail Image

Meningitis - Pipeline Review, H1 2017

  • Report
  • 54 Pages
From
Streptococcal Pneumonia - Pipeline Review, H1 2016 - Product Thumbnail Image

Streptococcal Pneumonia - Pipeline Review, H1 2016

  • Report
  • 139 Pages
From
Bacterial Pneumonia - Pipeline Review, H1 2016 - Product Thumbnail Image

Bacterial Pneumonia - Pipeline Review, H1 2016

  • Report
  • 200 Pages
From
Global Discovery Stage Partnering Terms and Agreements in Pharma and Biotech 2012- 2018 - Product Thumbnail Image

Global Discovery Stage Partnering Terms and Agreements in Pharma and Biotech 2012- 2018

  • Report
  • 1000 Pages
From
Seasonal Influenza Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Rising Elderly Population, Growing Awareness and Launch of Quadrivalent Therapies - Product Thumbnail Image

Seasonal Influenza Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Rising Elderly Population, Growing Awareness and Launch of Quadrivalent Therapies

  • Report
  • 108 Pages
From
Prosthetic joint infections - Pipeline Review, H1 2018 - Product Thumbnail Image

Prosthetic joint infections - Pipeline Review, H1 2018

  • Report
  • 44 Pages
From
Klebsiella pneumoniae Infections - Pipeline Review, H1 2018 - Product Thumbnail Image

Klebsiella pneumoniae Infections - Pipeline Review, H1 2018

  • Report
  • 110 Pages
From
Escherichia coli Infections - Pipeline Review, H1 2018 - Product Thumbnail Image

Escherichia coli Infections - Pipeline Review, H1 2018

  • Report
  • 190 Pages
From
Influenzavirus B Infections - Pipeline Review, H1 2018 - Product Thumbnail Image

Influenzavirus B Infections - Pipeline Review, H1 2018

  • Report
  • 129 Pages
From
Acinetobacter Infections - Pipeline Review, H1 2018 - Product Thumbnail Image

Acinetobacter Infections - Pipeline Review, H1 2018

  • Report
  • 154 Pages
From
Pseudomonas aeruginosa Infections - Pipeline Review, H1 2018 - Product Thumbnail Image

Pseudomonas aeruginosa Infections - Pipeline Review, H1 2018

  • Report
  • 260 Pages
From
Resistant Pseudomonas aeruginosa Infections - Pipeline Review, H2 2017 - Product Thumbnail Image

Resistant Pseudomonas aeruginosa Infections - Pipeline Review, H2 2017

  • Report
  • 54 Pages
From
Influenza B Infections - Pipeline Review, H2 2016 - Product Thumbnail Image

Influenza B Infections - Pipeline Review, H2 2016

  • Report
  • 71 Pages
From
Loading Indicator
adroll